Glioblastoma Multiforme Treatment Market is expected to expand at a CAGR of 8.8% from 2021 to 2028
Glioblastoma Multiforme Treatment Industry Overview The global glioblastoma multiforme treatment market size was valued at USD 2.14 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The growing prevalence of glioblastoma multiforme, increasing R&D, and favorable regulatory scenarios are among the factors anticipated to fuel the market growth. The presence of a strong pipeline is expected to act as a major driver for the glioblastoma multiforme (GBM) treatment market during the forecast period. The increasing incidence of brain tumors is expected to boost the growth of the market over the forecast period. According to Global Cancer Observatory, in 2020, the incidence of brain and CNS cancers was 308,102 globally and the number of deaths was 251,329 worldwide. Brain cancer is one of the deadliest forms of cancer. Gather more insights about the market drivers, restrains and growth of the Global Glioblastoma M...